search

Active clinical trials for "Carcinoma, Squamous Cell"

Results 1851-1860 of 1867

The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck...

Head and Neck Squamous Cell CarcinomaHuman Papillomavirus

This study is designed to refine the aetiological causes of cancers of the head and neck and investigate the ways in which human papillomavirus and life-style factors cause head and neck cancers. This study will determine if these factors affect the treatment of cancer. All patients attending the Head and Neck Clinic at the Princess Alexandra Hospital is invited to complete a risk factor questionnaire and give consent for their clinical data and tissue samples to be available for future research activities. The risk factor questionnaire is based on existing validated instruments developed by the QIMR Berghofer Medical Research Institute Cancer Control Group, and will collect standardised information relating to demographics and causal factors (tobacco and alcohol intake), risk modifiers (dentition, asprin and non-steroidal anti-inflammatory drugs (NSAIDS), height, weight, physical activity, diet quality etc) and behaviours (oral sex etc)

Unknown status2 enrollment criteria

Postmenopausal Women With Vaginal Microbiota

HPV-Related Squamous Cell Carcinoma

Since other genital infections enhance HIV susceptibility by inducing inflammation, the investigators study the relationship between the vaginal microbiota composition and the risk of HPV infection, cervical cytological abnormalities in postmenopausal women.

Unknown status2 enrollment criteria

Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal...

Oral Cavity Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma

The purpose of the study is to assess the role of lymphoscintigraphy as a simple and widely accessible method with a favorable cost/benefit ratio in improving oral cavity and oropharyngeal squamous cell carcinoma staging and surgical appropriateness and implementing a tailored surgical approach to cervical lymph node dissection.

Unknown status6 enrollment criteria

Surveillance of Peripheral Blood of Lymphocyte and Immunocyte in Neoadjuvant Therapy Patients With...

Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy1 more

Neoadjuvant chemoradiotherapy treatment represents the standard approach for resectable locally advanced esophageal squamous cell carcinoma. The incidence of pulmonary infection and other perioperative complications were higher in patients who received esophagectomy and neoadjuvant chemoradiotherapy than those without neoadjuvant treatment and surgery patients. However, reliable clinical data can quantify the damage degree of immunologic function caused by chemotherapy and radiotherapy is still unknown. This project regards the level of lymphocyte and immunocyte in peripheral blood as a quantitative index to reflect the dynamic change of the immunologic function of patients with locally advanced esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy treatment. Meanwhile, the investigators will also investigate the relationship between the level of lymphocyte and immunocyte in peripheral blood and the response rate of neoadjuvant therapy.

Unknown status27 enrollment criteria

The Aim of This Study is to Demonstrat That Vacuum-assisted Closure Versus Conventional Wound Closure...

MelanomaSkin Cancer3 more

In this study, we compared a negative pressure wound therapy, versus a conventional dressing in order to evaluate the most efficient wound therapy closure after axillary and inguinal lymph nodes dissections in the management of metastatic skin tumors. A vacuum assisted closure therapy should prevent these comorbidities.

Unknown status3 enrollment criteria

The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders...

Oral Potentially Malignant DisorderOral Cancer2 more

The mortality rate of oral cancer in Taiwan is still high with no decrease. One of the reasons result in these situations is the patent visits hospital for treatment in late stage of oral cancer. Recently, the government makes effort in oral cancer screening to find oral potentially malignant disorders (OPMD) early. However, there is no conscience in treatment strategies of OPMD up to now. In this study, we will set a OPMD data bank, and use the cases to find out the potential biomarker, which is able to predict the oral cancer malignant transformation. Sixty OPMD with oral cancer transformation will be recruited, and 60 OPMD with no oral cancer malignant transformation will also be enrolled as the disease control group. Besides, 20 normal cases and 60 oral cancer cases resulting from previous OPMD will be collected. All those groups will detect the expression of p62/SQSTM1 to investigate the possibility that p62/SQSTM1 as a biomarker to predict the malignant transformation of OPMM, and a guideline to treat or not to treat OPMD.

Unknown status2 enrollment criteria

Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva

Squamous Cell Carcinoma

Study comparing level of free radicals in tumor tissue, blood serum and saliva in patients with Squamous Cell Carcinoma of tongue and mouth floor. Patients with benign fibroma of oral cavity and normal gingiva around extracted lower wisdom tooth are used for control

Unknown status7 enrollment criteria

Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer

Squamous CarcinomaHead and Neck Cancer4 more

The study's aim is to define imaging and molecular bio-markers for prediction of radiotherapy response of squamous cell carcinomas, in an early treatment phase.

Unknown status10 enrollment criteria

The Role of microRNA-29b in the Oral Squamous Cell Carcinoma

Oral Cancer

The Role of microRNA-29b in the Oral Squamous Cell Carcinoma

Unknown status3 enrollment criteria

The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma

CarcinomaSquamous Cell

Head and neck Squamous Cell Carcinoma (HNSCC) is one of the most common head and neck malignant tumors .Investigators found that several patients with early TNM stage and poor differentiated HNSCC had poor prognosis, yet someone with advanced TNM stage and well differentiated HNSCC had good prognosis. Hence, Investigators suggested that prognosis factors and survival rates probably related to the differentiation of HNSCC, and prognosis factor of poorly differentiated HNSCC were rare discussed and controversy. Investigating the prognostic factors of poorly differentiated HNSCC is undoubtedly crucial.

Unknown status12 enrollment criteria
1...185186187

Need Help? Contact our team!


We'll reach out to this number within 24 hrs